sertindole: Clinical Trials

16 trials of sertindole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 4 terminated, 2 unknown. 7 Phase 3, 4 Not applicable, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 37Completed 5, Terminated 1, Unknown 1
Not applicable4Completed 2, Terminated 2
Phase 44Completed 2, Terminated 1, Unknown 1

Follow sertindole: new trials by email Literature Review of sertindole trials Research Report on sertindole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features
Phase 4CompletedTechnical University of Munich212015-02-012018-10-11
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
Asenapine, Aripiprazole, Quetiapine - Bipolar Disorder
CompletedOrganon and Co422013-04-012022-02-04
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
Discontinuation antipsychotic treatment, Antipsychotic treatment - Psychosis Nos/Other
Phase 3UnknownFundación Pública Andaluza Progreso y Salud1042012-11-012014-12-05
Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)
Sertindole, Olanzapine - Schizophrenia
Not applicableTerminatedUniversity of Aarhus112009-04-012013-09-04
Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
Sertindole, Risperidone - Schizophrenia
Phase 4UnknownSheba Medical Center602008-10-012009-03-25
The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia
risperidone, Sertindole - Schizophrenia
Phase 4TerminatedBirte Glenthoj12008-07-012020-03-26
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia
Sertindole, Quetiapine - Schizophrenia, Cognition
Phase 3CompletedH. Lundbeck A/S2642008-03-012014-05-28
The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients
Sertindole, Risperidone - Schizophrenia
Not applicableTerminatedUniversity of Zurich142008-02-012012-09-17
Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia
Sertindole - Schizophrenia
Phase 4CompletedH. Lundbeck A/S182007-11-012016-11-08
The Effect of Sertindole on Sensory Gating and Cognition in Healthy Volunteers
Sertindole, Placebo - Healthy
Not applicableCompletedUniversity of Zurich302007-09-012012-09-17
Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia
Sertindole, Olanzapine - Schizophrenia
Phase 3CompletedH. Lundbeck A/S2502007-03-012013-09-20
Sertindole in Asian Patients With Schizophrenia
Sertindole, Olanzapine - Schizophrenia
Phase 3CompletedH. Lundbeck A/S3942007-03-012013-09-20
Exploratory Cognition Study of Sertindole in Patients With Schizophrenia
Sertindole, Olanzapine - Schizophrenia
Phase 3CompletedH. Lundbeck A/S962006-10-012013-09-16
Augmenting Clozapine With Sertindole - SERCLOZ
Serdolect, placebo - Schizophrenia
Not applicableCompletedUniversity of Aarhus502006-09-012010-09-27
Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use
Sertindole, Risperidone - Schizophrenia
Phase 3CompletedH. Lundbeck A/S98092002-07-012011-08-19

Conditions studied

Schizophrenia (13)  ·  Anxiety Disorders (1)  ·  Bipolar Disorder (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)  ·  Depression (1)  ·  Psychophysiologic Disorders (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)

Sponsors

H. Lundbeck A/S (6)  ·  University of Aarhus (2)  ·  University of Zurich (2)  ·  Birte Glenthoj (1)  ·  Fundación Pública Andaluza Progreso y Salud (1)  ·  Hannover Medical School (1)  ·  Organon and Co (1)  ·  Sheba Medical Center (1)  ·  Technical University of Munich (1)

Countries

Denmark (3)  ·  China (2)  ·  Germany (2)  ·  Switzerland (2)  ·  France (1)  ·  Israel (1)  ·  Spain (1)  ·  Sweden (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Franz X. Vollenweider, Prof. Dr. med. (2)  ·  Birgitte Fagerlund, PhD (1)  ·  Birte Y Glenthoj, PhD (1)  ·  Bob Oranje, PhD (1)  ·  Helge Frieling, Prof., MD (1)  ·  Jimmi Nielsen, M.D. (1)  ·  Mark Weiser, Dr (1)  ·  Markus Dold, MD (1)  ·  Miguel Ruiz Veguilla, MD, PhD (1)  ·  Rita S Godske, MD (1)  ·  Stefan Leucht, Professor (1)

Results publications

PMID 18384186, PMID 20384598, PMID 20732794, PMID 20820795, PMID 20926264, PMID 21890590, PMID 22356584, PMID 22367659, PMID 23777311, PMID 25583364

NIH funding

2004 (1)